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Abstract
Cells from methylcholanthrene-induced tumor (MC-tumor), Ehrlich ascites cancer or mouse
ascites hepatoma (MH-134) were subcutaneously implanted in dorsal area of mice to examine the
specific cell mediated immunity following implantation. The migration index (MI) of lympho-
cytes was determined at various time periods after cell transplantation. The MI-activity increased
under all three implantations, reached maximum at a certain period, decreased gradually and disap-
peared. The maximum MI-activity coincided with the proliferation period of the implanted tumor
cells. This peak occurred on the tenth postimplantation day with MC-tumors, on the fifth day
with Ehrlich ascites cancer and on the sixth day with MH-134 cancer. In lymphoid tissues of ani-
mals with MC-tumor and Ehrlich ascites cancer, strong MI-activity appeared early in the regional
axillary lymph nodes, while weak activity was observed consistently in the distant mesenterial
lymph nodes. The MI-activity of the splenic lymphoid cells resembled the axillary lymph nodes
cell activity. The MI-activity of venous blood lymphoid cells was parallel to the average value of
lymphoid cells of the spleen and axillary and mesenterial lymph nodes.
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Abstract: Cells from methylcholanthrene-induced tumor (MC-
tumor), Ehrlich ascites cancer or mouse ascites hepatoma (MH-134)
were subcutaneously implanted in dorsal area of mice to examine the
specific cell mediated immunity following implantation. The migra-
tion index (MI) of lymphocytes was determined at various time periods
after cell transplantation. The MI-activity increased under all three
implantations, reached maximum at a certain period, decreased gra-
dually and disappeared. The maximum MI-activity coincided with
the proliferation period of the implanted tumor cells. This peak
occurred on the tenth postimplantation day with MC-tumors, on the
fifth day with Ehrlich ascites cancer and on the sixth day with MR-
134 cancer. In lymphoid tissues of animals with MC-tumor and Ehr-
lich ascites cancer, strong MI-activity appeared early in the regi6nal
axillary lymph nodes, while weak activity was observed consistently in
the distant mesenterial lymph nodes. The MI-activity of the splenic
lymphoid cells resembled the axillary lymph nodes cell activity. The
MI-activity of venous blood lymphoid cells was parallel to the average
value of lymphoid cells of the spleen and axillary and mesenterial
lymph.nodes.
In both implanted and spontaneous tumors, the host lymphocyte anti-
tumor activity appears first at the regional lymph nodes. The antitumor
activity of the regional lymph nodes decreases as the tumor reaches a certain
size. The antitumor activity then appears in more distant lymph nodes. (20,
21,22,27,28)
Free target tumor cells used for the lymphocytotoxicity test are difficult to
prepare from solid tumor tissue obtained during surgery. For this reason,
the macrophage migration inhibition test (MI-test) which requires no primary
cuIture of target tumor cells is useful for examining the parameters of
specific concomitant immunity. In previous studies the lymphoid cell MI-
activity was correlated to the tumor stage in cancer-bearing animals, and this
data was consistent with the lymphocytotoxicity test (20,21,22,23,24). Other
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reports (1-8) have demonstrated that the MI-test indicates delayed hyper-
sensitivity specifically and sensitively and that this'test is applicable to cell-
mediated tumor immunity. (9)
MATERIALS AND METHODS
Experimental animals. The animals used were C3H and CHA strain mice,
4 to 6 weeks of age, weighing about 20g (research colony of Okayama Univer-
sity Medical School). They were fed on Solid Feed MF (Oriental Yeast Co.).
Guinea pigs employed were a hybrid strain, weighing 300 to 500g and were
maintained on Solid Feed MF.
Experimental tumors. Three kinds of tumors were used. (aJ Methylcholan-
threne induced sarcoma (MC-tumor). One milligram of 2O-methylcholanthrene
(Woko Co.) suspended with O.lml of arabian gum was injected ,subcutaneously
into the dorsal region of C3H mice. The tumor was allowed to grow for about
three months and was transplanted to mice of the same strain successively for
at least the third generations. (b) Ehrlich ascites cancer. Samples were obtained
from the S~ction of Pathology, Okayama University Cancer Institute and main-
tained in the peritoneal cavity of Cb strain mice by successive passages. (c) C3H
mouse ascites hepatoma 134 (MH-134)." Samples were supplied by Dr. G. Fujii
of the Medical Laboratory, Tokyo University and maintained in the peritoneal
cavity of C3H mice by successive passages.
Tumor implantation. The MC-tumor was allowed to grow to about lcm
diameter and removed for implantation. A tumor mass of about Imm3 was
implanted subcutaneously between the scapulas dorsally on another mice of
the same strain. Such implantations were conducted on 30 C3H mice. Four
mice each were sacrificed at 3, 7, 10, 14, 21 and 28 days after tumor iso-trans-
plantation (six animals died during the study). The axillary and mesenterial
lymph nodes, spleen and sometimes blood from the inferior caval vein were
collected. The axillary lymph nodes of six normal mice not transplanted with
tumor were examined as controls. Ehrlich ascites cancer cells (5x 106 ) suspended
in 0.1 ml of 0.9% NaCl solution were injected subcutaneously into the dorsal
site of 20 CBA strain mice. Four mice each were sacrificed at 3, 5, 7, 10 and 14
days after homo-transplantation. The four axillary lymph n'odes, two mesen-
terial'lymph nodes and spleen were collected. MH-134 cancer at 2x 104 cells
was suspended in 0.1 ml of 0.9% NaCI solution. This suspension was iso-
transplanted subcutaneously into the dorsal region of 20 C3H mice. Two mice
each were sacrificed at 2,4, 6, 8 and 10 days after implantation. The axillary
and cervical lymph nodes were collected. Such implanted tumor masses and
tumor cell numbers were sufficient for tumor development and eventual host
death.
Crude antigen. The collected tumors were stored at - 20°C and were used
in the preparation of antigens. The tumor was cut into fine pieces in 0.9%
NaCI solution and homogenized by supersonication for 10 minutes at 20 kc,
7 tip, 150mA. After the homogenate was clarified by centrifugation at 3000rpm
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for 30 min, the supernatant was used as the test solution containing soluble
antigen. On the basis of preliminary experiments, the protein concentration
was adjusted so that the migration of macrophage was specifically inhibited. _
Peritoneal exudative cells. Peritoneal exudatives were induced in guinea
pigs by intraperitoneal injection of 20 ml of liquid paraffin. The exudates were
harvested 4 to 6 days later, and after washing 3 times in Hanks' solution, peri-
toneal cells were suspended in TC-medium 199 and adjusted to a concentration
of 2-5 x 108 cells/ml.
Lymphoid cells. The collected lymphoid tissues were sliced into fine pieces
with ophthalmic scissors and passed through BO-mesh filter. The filtrate was
washed with cold Hanks' solution by centrifugation at 2000rpm for 5 minutes.
The washings were repeated 3 times. The final precipitate was suspended in
TC-medium 199 containing 20% fetal calf serum. Lymphoid cells were prepared
from the spleen by a similar method, and red cells were destroyed in 0.35%
hypotonic saline solution. The isolation of venous blood lymphoid cells was
performed by density gradient centrifugation using Ficoll and Conray 400.
Macrophage migration inhibition test. Migration inhibition factor was pro-
duced by incubating lymphoid cells at 3x 106/ml mixed with crude soluble
antigen. After incubation for 24 hours at 37°C in 5% CO2 containing air, the
cells were sedimented by centrifugation at 3000rpm for 30 min, and supernatant
assayed for migration inhibition factor. The suspension containing peritoneal
exudative cells was drawn into capillary tubes (1.3 to 1.5mm in diameter, 75mm
long, closed at one side) and centrifuged at BOOrpm for 5 min. The tubes were
cut at the cell-medium interphase and the part containing the cells was fixed
on a cover slip in a small culture chamber of 1ml capacity with a drop of
silicon grease (High Vacuum, Dow-Corning). Four chambers were divided
into two groups; one group was filled with the supernatant assayed for MIF,
and the other group was filled with the supernatant without antigen. After
incubation for 24 hours at 37°C in 5% CO2 containing air, the migrated area
was measured by projecting the microscopic image of cell growth from each
capillary onto cellophane paper. The outline of the migration was drawn and
measured on graph paper. The average area was calculated with at least four
capillary tubes. The following formula was used to calculate the macrophage
migration inhibition activity.
Average area of migration with antigen 100 M" . I d (MI) ( )
A- f·"· h . x = IgratlOn n ex %verage area 0 mIgratIOn wIt, out antIgen '
From our preliminary data, 80% MI was designated as borderline of MIF posi-
tive and negative.
RESULTS
MI-activity of lymphoid cells from the axillary lymph nodes from MG-
tumor bearing mice turned positive on posttransplantation day '7, reached
maximum on day 10, decreased gradually thereafter and disappeared on day
21. The MI-activity of the spleen showed changes similar to the axillary
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lymph nodes, reaching maximum during days 7 to 14 and disappeared by day
21. -On the other hand, the MI-activity of the mesenterial lymph nodes was
generally weak and disappeared later than the regional lymph nodes. The
MI-activity of peripheral blood lymphocytes was parallel to the average
value of the lymphoid cells of the spleen and the collected lymph nodes.
(Table 1, Fig. 1) The MI-activity of the regional lymph nodes was maximum
on the 10th day after transplantation, when tumors were palpable. The MI-
activity decreased thereafter. Most mice had tumor death by 5 to 7 weeks
after transplantation. (Fig. 2)
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Fig. 1. Time-lapse changes of MI-activity after methylcholanthrene-
induced sarcoma (MC-tumor) cell iso-transplantation. MI-activity of lym-
phoid cells derived from normal mice (I), and from the axillary lymph
nodes (II), mesenterial lymph nodes (III), spleen (IV) and venous blood (V)
of MC-tumor transplanted mice.
TABLE 1 TIME-LAPSE CHANGES IN MI-ACTIVITY AFTER MC-TUMOR IMPLANTATION IN MICE
Days after transplantation (Mean M.1. %±S.E.)
3 7 10 14 21 28
Axillary lymph 96.7±16.4 66.4±18.0 51.7±11.3 78. 6±6. 7 93. O± 13. 6 112. 5± 15.6
node
Spleen 106.9±22.9 71.8± 11.1 72.l±14.0 72. 4± 11.0 92.2±28.4 108.0±23.6
Mesenterial 87. 7±22. 7 83.0±18.9 95.8± 15.1 82.9±7.l 81.9±8.2 1l0.8± 18. 6lymph node
Venous blood 84.2 73.9 64.5 69.8 84.3 Not tested
Each value represents the mean of 10 experiments except for the venous blood values
which were based on 4 mice at each time period.
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Fig. 2. Growth curve of tumor after iso-transplantation of Imm3 MC-tumor.
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MI-activity of lymphoid cells from the axillary lymph nodes from Ehrlich
ascites cancer bearing mice reached maximum at posttransplatation day 5,
and thereafter the MI-activity decreased and disappeared by day 14. Spleen
cells from these mice showed positive MI-activity from day 5 to 7 and there-
after disappeared gradually in a pattern similar to the regional lymph nodes.
In the distant mesenterial lymph nodes, MI-activity was maximal though
weak on day 10. (Table 2, Fig. 3) The tumor was palpable on about day 4,
and by 3 to 4 weeks the tumor led to host death. (Fig. 4)
In lymphoid cells isolated from the axillary and cervical lymph nodes
after implantation of MH-134 cancer, the MI-activity appeared strongest on
TABLE 2 TIME-LAPSE CHANGES IN MI-ACTIVITY AFTER EHRLICH ASCITES CANCER
CELL TRANSPLANTATION
Days after transplantation (MI %)
3 5 7 10 14
Axillary lymph node Exp.l 92.8 70.0 78.4 83.2 104.7
Exp.2 90.2 67.4 73.9
Spleen Exp. 1 97.5 74.5 72.3 89.1 101.4
Mesenterial lymph node Exp. 1 87.4 105.9 84.5 85. 7 109.3
Exp. 2 98.6
Each value represents the mean of 4 mice. The axillary lymph node and mesenterial
lymph node studies were conducted twice.
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Fig. 3. Time-lapse changes in MI-activity after Ehrlich ascites
cancer homo-transplantation. MI-activity of lymphoid cells from axil-
lary lymph nodes (I), spleen (II) and mesenterial lymph nodes (III)
from Ehrlich ascites cancer transplanted mice.
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Fig. 4. Growth curve of tumor after homo-transplantation of
5 X 1()6 Ehrlich ascites cancer cells.
day 6 after implantation and decreased gradually thereafter (Table 3, Fig. 5).
The tumor proliferation after implantation of 2 X 104 MH-134 cancer cells is
shown in Fig. 6.
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TABLE 3 TIME-LAPSE CHANGES IN MI-ACTIVITY AFTER MH-13\ CANCER CELL
TRANSPLANTATION IN THE REGIONAL AXILLARY AND CERVICAL
LYMPH NODES OF MICE
Days after transplantation (MI %)
2 4 6 8 10
Exp. 1 91.6 76.3 66.4 79.1 75.5
Exp.2 101.0 72.3 54.6 69.8 88.2
The experiment was repeated twice.
50
oT
2 4 6 8 10
Days after implantat ion
Fig. 5. Time-lapse changes of MI-activity after MH-134
cancer cell iso-transplantation. The lymphoid cells used were
prepared from regional axillary and cervical lymph nodes of
mice.
4.0
1.0
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.'.O~--~----.-----CD--- --__-
4 6 8 10 12 14
Days after implantation
Fig. 6. Growth curve of tumor after iso-transplantation of 2 x 104
MH-134 cancer cells.
43
7
Yumura: Macrophage migration inhibition-activity after implantation of
Produced by The Berkeley Electronic Press, 1976
44 M. YUMURA
In all three implanted experimental tumors lymphoid cell MI-activity
increased in the regional lymph nodes to a maximal point, and as this activity
began to diminish, tumor growth was initiated.
DISCUSSION
It is generally agreed that experimental tumors induced by chemical
carcinogens and oncogenic viruses as well as spontaneous tumors and human
cancers all possess tumor-associated antigen on the cell surface. This finding
was first definitively demonstrated by Klein. et ai. (10) using Me-tumors.
Despite the possession of tumor specific transplantation antigen (TSTA) by
tumor cells, cancer ultimately led to host death without resistance to cancer.
However, it is generally recognized that cancer-bearing bodies identify TSTA
and try to eliminate the cancer cells. This reaction is known as concomitant
immunity, in which lymphocytes playa principal role. Since the presence
of TSTA and the cell-mediated immunity by lymphocytes are now well
established, immunological examinations of cancer-bearing subjects are being
conducted on specific cell-mediated immunity with the cytotoxicity test, the
colony inhibition test, the mixed lymphocyte-target cell interaction, the adop-
tive transfer and the neutralization test, and on non-specific cell-mediated
immunity with blastfonnation against PHA.
The present MI-test is one method for studying specific cell-mediated
immunity. In 1932 Rich and Lewis (11) found when antigen was added to
spleen tissue cultures of sensitized animals, cell migration from spleen tissue
were inhibited. These investigators pointed out that such a phenomenon
can be used to test for delayed hypersensitivity reaction. George and
Vaughan (12) in 1962 found that the addition of purified protein derivative
(PPD) to culture medium inhibited the migration of peritoneal exudative
cells enclosed in capillary tubes prepared from tuberculin positive guinea
pigs. They found that the degree of migration inhibition correlated with the
delayed type skin reaction. Bloom and Bennett (13) divided peritoneal exu-
dative cells of guinea pigs sensitized with bacillus Calmette-Guerin (BOG) into
lymphocytes and macrophages. Each cell type was placed into separate capil-
lary tubes and similar experiments were conducted. These investigators
demonstrated that macrophages under such conditions exist as indicator cells.
In addition, they reported a soluble factor produced from sensitized lympho-
cytes during contacts with antigen inhibited the migration of macrophages
prepared from nonsensitized guinea pigs. This phenomenon was confirmed
by David (14), and this soluble factor was later designated as the macrophage
migration inhibition factor (MIF). The results of MI-test using PPD (12, 16),
ovalmin (1), diphtheria toxoid (1), histoplasmin (15) or streptokinase-strepto-
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dornase (16) as antigens coincided closely with the results of the delayed type
skin reaction using these same antigens. In humans the tuberculin test results
agree with those of the MI-test. The MI-test with tumor had its origins in
the tests of Bloom and Bennett (19) on tumor homogenate as antigen. In MI-
tests on MC-sarcoma induced in C3H mice as well as on spontaneous carci-
noma, Vaage, David and Brown (18) stated that the test correlated closely
with the antitumor activity of lymphocytes and that the activity was specific
to the tumor antigen. In the present study the indirect method of MI was
determined in which the soluble factor produced when lymphoid cells in-
cubated with tumor homogenate inhibited the migration of nonsensitized
guinea pig macrophages. It has also been shown that the MI time-lapse
changes occurred after iso-transplantation of methylcholanthrene induced
sarcoma and MH-134 ascites tumor and after homo-transplantation of Ehrlich
ascites cancer. The MI-activity of the regional lymph nodes reached maxi-
mum at a time coinciding with the start of tumor growth, and the activity
gradually decreased as the tumor grew. The MI-activity finally disappeared.
The course of this MI-activity was invariably related to tumor growth irre-
spective of the tumor type. It is not clear whether the decreased MI-
activity accompanying tumor growth is induced by a toxohormone-like sub-
stance produced from the tumor or by a humoral factor as a blocking anti-
body. Cerilli and Smith (19) reported that MI-activity increased linearly to
the eleventh post-transplantation day with MC-tumor. This data coincides
with the present experiment. Kashihara (20) observed a strong lymphoid cell
antitumor activity on the first and second week after transplantation in neu-
tralization test transplanting a mixture of tumor cells and lymphoid cells from
regional lymph nodes obtained after subcutaneous transplantation of MC-
tumor cells in the dorsal regions of untreated mice. Ohsugi (21) likewise
found at the 14th post-transplantation day of MC-tumor iso-transplantation
that lymphoid cells from the regional lymph nodes markedly inhibited the
in vitro proliferation of Me-tumor cells. The same author (22) also observed
the strongest antitumor activity when mammary tumors grew to about 10%
of body weight in in vitro experiment with splenic lymphoid cells of C3H and
Rm strain mice bearing spontaneous mammary carcinoma. Hara (23) ob-
served strong cytotoxic activity in the first week when JTC-ll cells derived
from Ehrlich ascites cancer were incubated with lymphoid cells from mice
transplanted with Ehrlich ascites cancer. Satoh (24) conducted similar experi-
ments with A cells derived from C3H mouse mammary cancer and observed
strong antitumor activity on day 10 or 14 after iso-transplantation. The
activity then decreased and disappeared. Deckers et ale (25) iso-transplanted
MC-tumor subcutaneously in mice. Nontreated mice transplanted i. p. with
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spleen cells obtained 7 to 14· days after tumor iso-transplantation indicated
growth inhibition of simultaneously implanted subcutaneous MC-tumor.
From these findings it seems that tumor bearing animals have strong antitumor
activity to autochthonous tumor as concomitant immunity, and the activity
decreases when the tumor increased beyond a certain period, although the time
period may differ in each tumor.
MI-activity appeared earliest and strongest in the regional axillary lymph
nodes of mice implanted MC-tumor and Ehrlich ascites cancer cells. In the
distant mesenteriallymph nodes weak MI-activity was persistently observed.
This can be explained as TSTA flows out of the tumor then enters the
regional lymph nodes, where concomitant immunity is first established, as
stated by Fisher et at. (26). In subcutaneous dorsal implantation of Ehrlich
ascites cancer in mice, Orita et at (27) removed the regional axillary and
distant mesenterial lymph nodes and spleen. They conducted cultures of
mixed lymphoid cells prepared from each of these tissues and JTC-l ~ cells
derived from Ehrlich ascites cancer. On post-transplantation day 8 antitumor
activity was not observed in the spleen and mesenteriallymph nodes but the
regional axillary lymph nodes indicated activity. On day 21 the mesenterial
lymph nodes showed antitumor activity. A time difference was thus found
in the appearance of antitumor activity depending on the site. Orita et al. (28)
observed differences in cytotoxic activity between the regional lymph nodes
and distant lymph nodes in mixed cultures of node cells and autochthonous
primary tumor cells from extirpated tumor tissues, such as gastric and mam-
mary cancer.
The MI-test originally used for evaluating delayed hypersensitivity was
sensitive for measuring concomitant immunity, and it has been used clinically
because of its reliability and the ease of adjusting antigen. There are many
reports (29, 30, 31) of decreased lymphocyte MI-activity in various advanced
cancer bearing patients. The described time-lapse observations of MI-activity
changes after tumor transplantation may be a useful index for determining the
advance of malignant tumor.
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